NFE2L2 and neoplasm: The observed increase in GSH levels is due not only to the higher levels of ROS production in most tumor cells but also to the fact that some of the classical tumor promoters also activate GSH synthesis and turnover mechanisms (e.g., Nrf2) [25,88].